Skip to main content
Log in

Making drug addicts out of yeast

  • News & Views
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Yeast has been engineered so that the binding of small-molecule ligands to a target protein can be simply detected by changes in growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Yeast dhr1 mutant strains carrying a murine DHFR chimeric protein can be used as a biosensor for drug discovery.

© Bob Crimi

References

  1. Pandey, A. & Mann, M. Nature 405, 837–846 (2000).

    Article  CAS  Google Scholar 

  2. Tucker, C.L. & Fields, S. Nat. Biotechnol. 19, 1042–1046 (2001).

    Article  CAS  Google Scholar 

  3. Klein, C. et al. Nat. Biotechnol. 16, 1334–1337 (1998).

    Article  CAS  Google Scholar 

  4. Licitra, E.J. & Liu, J.O. Proc. Natl. Acad. Sci. USA 93, 12817–12821 (1996).

    Article  CAS  Google Scholar 

  5. Remy, I. & Michnick, S.W. Proc. Natl. Acad. Sci. USA 96, 5394–5399 (1999).

    Article  CAS  Google Scholar 

  6. Collinet, B. et al. J. Biol. Chem. 275, 17428–17433 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vidan, S., Snyder, M. Making drug addicts out of yeast. Nat Biotechnol 19, 1022–1023 (2001). https://doi.org/10.1038/nbt1101-1022

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1101-1022

  • Springer Nature America, Inc.

This article is cited by

Navigation